SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of a major industry shift following news that it will acquire Boeings Wisk Aero, SkyGrid, and Insitu units, a deal that includes a nearly 20% equity stake from Boeing and provides Archer with a established defense revenue stream. While the community is actively debating the implications of potential dilution against the benefits of these new assets, the stock remains a focal point for investors weighing its long-term aerospace platform potential against near-term certification risks.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors digest a major expansion of its U.S. manufacturing footprint alongside strong institutional backing, fueling optimism around its pivotal role in the AI optical networking bottleneck. The community is actively debating the sector's long-term growth potential and the impact of potential trade restrictions on Chinese optical components as demand for high-speed connectivity scales.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant market discussion as investors anticipate topline Phase 3 IZAR-1 data, with community sentiment split between frustration over timing delays and high conviction in the drug's long-term potential. While the stock faces volatility and bearish short-term pressure, many retail and institutional holders remain focused on the broader multi-indication strategy and potential for a strategic exit if trial results validate its efficacy profile.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings ($LITE) is experiencing intense volatility as investors debate the impact of potential U.S. restrictions on Chinese-made optical transceivers and data center components. While community members remain divided on whether these policy shifts will create a domestic supply chain advantage or trigger retaliatory supply bottlenecks, the stock continues to be a focal point for institutional accumulation and high-conviction momentum trading.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following the announcement of a strategic collaboration with Vertex Pharmaceuticals, a move that reinforces the credibility of its proprietary T-cell engager platform alongside recent partnerships. Community sentiment remains highly divided between long-term investors focused on platform validation and clinical progress toward upcoming Phase 2 data readouts, and skeptics who remain frustrated by the stock's multi-year price decline and perceived management underperformance.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors digest a strong earnings report showing a double-digit rise in operating profit and a strategic pivot from net seller to net buyer of equities. While some community members remain frustrated by the stock's long-term price stagnation and lack of dividends, others are highlighting the company's massive cash deployment and defensive value as key catalysts for potential upside.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing increased volatility as investors weigh strong earnings and AI-driven growth against concerns over high valuations and acquisition-related costs. The community remains divided, with many traders debating whether to buy the dip during this pullback or lock in profits after the stock's significant run-up to all-time highs.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer Technologies is drawing intense community focus following the announcement of a massive 16-year data center lease in Norway, though the stock has struggled to maintain momentum amidst broader sector volatility. Investors are actively debating the company's long-term pivot toward AI and HPC infrastructure, with many looking for a definitive 'show-me' catalyst like a signed contract with a major hyperscaler to trigger a valuation re-rating.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following news that its ultrasound-on-chip technology is being integrated into a new AI-powered full-body scanner developed by Midjourney. The community is actively debating the stock's long-term growth potential and high short interest versus risks of future dilution and potential profit-taking.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending following a significant 80 million dollar public offering priced at five dollars per share, which has sparked intense debate among investors regarding the resulting equity dilution and the company's long-term capital strategy. The community is actively weighing the potential impact of this cash infusion on the commercialization of Eversense 365 against concerns over share count expansion, management's fiscal track record, and the upcoming first-quarter earnings report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Panacea Life Sciences Holdings, Inc. engages in the development and production of medically relevant, legal, hemp-derived cannabinoid products for consumers and pets. Its products include food and beverages, pharmaceuticals, cosmetics, beauty, personal care, pet and industries. The company was founded on January 18, 2008 and is headquartered in Greenwood Village, CO.

Panacea Life Sciences Hldgs Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info